Inhaltsbereich
| 5556 Einträge | « ‹ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 › » |
Seite 14 / 278
 Druckansicht
|
| 1499PEFFECTIVENESS OF DARBEPOETIN ALFA (DA) FOR CHEMOTHERAPY-INDUCED ANAEMIA (CIA) WHEN INITIATED AT HAEMOGLOBIN (HB) ≤10 G/DL. |
| Pirker R, Vansteenkiste JF, Hedenus M, Hernandez E, Belton L, Terwey J |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2242185. doi: 10.1093/annonc/mdu356.20 |
| PMID: 28172008 |
| 1239PFEASIBILITY OF HOME DELIVERY (HD) OF MAINTENANCE PEMETREXED (PEM) THERAPY FOR ADVANCED NONSQUAMOUS NON SMALL CELL LUNG CANCER (ADV NSQNSCLC). |
| Lal R, Summers Y, Shah R, Crosse B, Thompson J, Nicolson MC, Potter V, Visseren-Grul CM, Vikström A, Lorenzo M, D'Yachkova Y, Bourayou N, Hillerdal G |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241952. doi: 10.1093/annonc/mdu349.18 |
| PMID: 28171966 |
| 773PMULTICENTER, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY OF SORAFENIB COMPARED TO PLACEBO WITH BEST SUPPORTIVE CARE AFTER FAILURE OF DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER. |
| Kramer G, Maj-Hes A, Hobisch A, Shariat SF, Loidl W |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2238904. doi: 10.1093/annonc/mdu336.21 |
| PMID: 28171945 |
| 743TiPAN INTERNATIONAL OBSERVATIONAL STUDY TO ASSESS THE USE OF SORAFENIB AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): OPTIMIS. |
| Raoul J, Peck-Radosavljevic M, Lee HC, Kudo M, Nakajima K, Cheng A |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241415. doi: 10.1093/annonc/mdu334.128 |
| PMID: 28171929 |
| 1143PPH II STUDY OF BEZ235 IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) AFTER MTOR INHIBITOR THERAPY FAILURE: STAGE I INTERIM RESULTS. |
| Fazio N, Buzzoni R, Baudin E, Antonuzzo L, Hubner R, Lahner H, De Herder WW, Raderer M, Teule A, Capdevila J, Libutti S, Kulke M, Shah M, Dey D, Turri S, Aimone P, Verslype C |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241845. doi: 10.1093/annonc/mdu345.12 |
| PMID: 28171536 |
| 812PDMATURE SURVIVAL (OS) DATA OF A RANDOMISED INTERNATIONAL PHASE II TRIAL (JASINT1): VINFLUNINE (VFL)-GEMCITABINE (GEM) VS. VFL-CBDCA IN CDDP-UNFIT PATIENTS (PTS) WITH ADVANCED UROTHELIAL CARCINOMA (UC). |
| De Santis M, Wiechno PJ, Lucas C, Lin C, Su W, Bellmunt J, Legrand K, Fougeray R, Culine S |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241576. doi: 10.1093/annonc/mdu337.5 |
| PMID: 28171465 |
| 1589PCOMPARISON OF THE CARDIOTOXIC EFFECT OF DOXORUBICIN AND LIPOSOME-ENCAPSULATION OF DOXORUBICIN UNDER EXPERIMENTAL CONDITION. |
| Gyöngyösi M, Maurer G, Bergler-Klein J |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2242269. doi: 10.1093/annonc/mdu358.20 |
| PMID: 28171415 |
| 1511PSOMPAS: A PROSPECTIVE, NON-INTERVENTIONAL STUDY (NIS) OF THE MANAGEMENT OF SYMPTOMATIC CHEMOTHERAPY (CT)-INDUCED ANEMIA (CIA) IN PATIENTS (PTS) WITH COLORECTAL (CRC), BREAST (BC) OR LUNG CANCER (LC) IN AUSTRIA (AT) AND SWITZERLAND (CH). |
| Eisterer W, Trojan A, Galid A, Haslbauer F, Delmore G, Kolb R, Jaeger C, Bast C, Pezzani I, Schmid M |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2242198. doi: 10.1093/annonc/mdu356.32 |
| PMID: 28171371 |
| 1348PA NATIONWIDE SURVEY ON PALLIATIVE SEDATION FOR TERMINALLY ILL CANCER PATIENTS BY THE AUSTRIAN PALLIATIVE CARE (AUPAC) STUDY GROUP. |
| Schur S, Masel EK, Mayrhofer M, Watzke HH |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2242044. doi: 10.1093/annonc/mdu350.12 |
| PMID: 28171324 |
| 1077TiPIMMUNOMODULATORY MAINTENANCE THERAPY WITH TLR-9 AGONIST MGN1703 IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA-THE RANDOMIZED PHASE 3 IMPALA STUDY. |
| Arnold D, Zurlo A, Salazar R, Ducreux MP, Waddell T, Stein A, Tournigand C, Scheithauer W, Sobrero A, Van Cutsem E, Cunningham D |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241787. doi: 10.1093/annonc/mdu342.30 |
| PMID: 28171288 |
| 1252PNSCLC PATIENTS WITH BRAIN METASTASES TREATED WITH PLATINUM-BASED DOUBLETS AS FIRST-LINE THERAPY: ANALYSES FROM THE EUROPEAN FRAME OBSERVATIONAL STUDY. |
| Moro-Sibilot D, Smit EF, Carpeño JC, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith K, Girvan A, Visseren-Grul CM, Schnabel PA |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241967. doi: 10.1093/annonc/mdu349.31 |
| PMID: 28171285 |
| 436PPOPULATION-BASED INCIDENCE AND OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA - A STUDY BY THE AUSTRIAN BRAIN TUMOR REGISTRY, 2005-2010. |
| Woehrer A, Hackl M, Waldhör T, Hainfellner J, Berghoff AS, Preusser M |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241183. doi: 10.1093/annonc/mdu330.23 |
| PMID: 28171276 |
| 1061PIMPACT STUDY: A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS WITH VERY PROLONGED DISEASE CONTROL UNDER MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703. |
| Scheithauer W, Riera-Knorrenschild J, Kopp H, Mayer F, Nitsche D, Kuhlmann J, Ziebermayr R, Andel J, Arnold D, Schmidt M, Schmoll HJ |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241769. doi: 10.1093/annonc/mdu342.14 |
| PMID: 28171274 |
| 1247PANALYSIS OF PATIENTS TREATED WITH CISPLATIN OR CARBOPLATIN-BASED DOUBLET CHEMOTHERAPY IN THE EUROPEAN FRAME OBSERVATIONAL STUDY. |
| Smit EF, Moro-Sibilot D, Carpeño JC, Kmak-Lesniewski K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith K, Girvan A, Visseren-Grul CM, Schnabel PA |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241961. doi: 10.1093/annonc/mdu349.26 |
| PMID: 28171248 |
| 353OEFFICACY AND SAFETY IN TANIA, A RANDOMISED PHASE III TRIAL OF CONTINUED OR REINTRODUCED BEVACIZUMAB (BEV) AFTER 1ST-LINE BEV FOR HER2-NEGATIVE LOCALLY RECURRENT/METASTATIC BREAST CANCER (LR/MBC). |
| von Minckwitz G, Puglisi F, Cortes J, Vrdoljak E, Marschner N, Zielinski C, Villanueva CB, Romieu G, Láng I, Ciruelos E, De Laurentiis M, Veyret C, De Ducla S, Freudensprung U, Srock S, Gligorov J |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241122. doi: 10.1093/annonc/mdu329.3 |
| PMID: 28171246 |
| 1136PDQUALITY OF LIFE (QOL) WITH LANREOTIDE AUTOGEL (LAN) VS. PLACEBO IN PATIENTS WITH ENTEROPANCREATIC NEUROENDOCRINE TUMOURS (EP-NETS): RESULTS FROM THE CLARINET PHASE III STUDY. |
| Ruszniewski P, Caplin M, Pavel M, Ćwikła J, Phan A, Raderer M, Sedlackova E, Cadiot G, Wall L, Rindi G, Langley A, Blumberg J, Gomez-Panzani E |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241871. doi: 10.1093/annonc/mdu345.5 |
| PMID: 28171202 |
| 845PEVEROLIMUS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) REFRACTORY TO ANTI-VEGF THERAPY: UPDATED RESULTS OF A POOLED ANALYSIS OF NONINTERVENTIONAL STUDIES. |
| Sauvin LA, Kube U, Eymard J, Schmidinger M, Bamias A, Kelkouli N, Mraz B, Florini S, Rose C, Cattaneo A, Bergmann L |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241563. doi: 10.1093/annonc/mdu337.38 |
| PMID: 28170943 |
| 502PDMOSAIC STUDY: ACTUALIZATION OF OVERALL SURVIVAL (OS) WITH 10 YEARS FOLLOW UP AND EVALUATION OF BRAF. BY GERCOR AND MOSAIC INVESTIGATORS. |
| André T, De Gramont A, Chibaudel B, Raballand A, Duval A, Hickish T, Tabernero J, van Laethem J, Banzi M, Maartense E, Shani A, Carlsson G, Scheithauer W, Papamichael D, Moehler M, Landolfi S, Demetter P, Dumont S, Fléjou J, De Gramont A |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241319. doi: 10.1093/annonc/mdu333.5 |
| PMID: 28170837 |
| 610TiPLUME-COLON 1: DOUBLE-BLIND, RANDOMISED PHASE III STUDY OF NINTEDANIB (BIBF 1120) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IN PATIENTS (PTS) WITH REFRACTORY COLORECTAL CANCER. |
| Van Cutsem E, Tabernero J, Yoshino T, Sassi M, Oum'Hamed-Mansour Z, Studeny M, Lenz H |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241268. doi: 10.1093/annonc/mdu333.111 |
| PMID: 28170817 |
| 396PUSE OF LIPOSOMAL DOXORUBICIN FOR METASTATIC BREAST CANCER MANAGEMENT ACROSS EUROPE: RESULTS OF EOS (EUROPEAN OBSERVATORY & SURVEY). |
| Lorusso V, Śmiałowska-Janiszewska A, Krzemieniecki K, Novoa SA, Mefti F, Janssen J, Steger GG, Bird B, Turazza M, Yosef H, Albuisson E, Barnadas A, Batist G, De Mouzon J, Erdkamp F, Leonard R, Namer M, Maumus-Robert S, Aapro MS |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241140. doi: 10.1093/annonc/mdu329.45 |
| PMID: 28170758 |
| 5556 Einträge | « ‹ 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 › » |
Seite 14 / 278
Druckansicht
|
Schnellinfo
Featured
